1. Drugmaker has to pay $8 billion after men develop breasts, jury says  East Idaho News
  2. Whopping jury award against Johnson & Johnson sends a signal to drug industry  msnNOW
  3. Johnson & Johnson has to pay $8 billion after male breast growth linked to antipsychotic drug, jury says  FOX 59 Indianapolis
  4. J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case  Yahoo Finance
  5. Johnson & Johnson to Pay $8 Billion in Damages After Man Says He Developed Breasts After Taking Antipsychotic Drug  KTLA Los Angeles
  6. View full coverage on Google News
(CNN) — Johnson & Johnson will have to pay $8 billion in punitive damages after a man claims the company didn’t warn young men that the drug Risperdal could grow breasts, a jury said Tuesday, according to Reuters. Nicholas Murray, 26, previously won $680,000 in the case over the antipsychotic drug Risperdal in the Philadelphia […]

Drugmaker has to pay $8 billion after men develop breasts, jury says | East Idaho News

Johnson & Johnson will pay damages to Philly man, Nicholas Murray, who took their drug Risperdal when he was a child and it made him grow large breast.Johnson & Johnson will pay damages to Philly man, Nicholas Murray, who took their drug Risperdal when he was a child and it made him grow large breast.

Philly Man Wins $8B From Johnson & Johnson Over Drug That Made Him Grow Breasts Like A Woman

West Virginia on Wednesday sued Johnson & Johnson over its marketing of a surgical mesh used to treat pelvic conditions in women after regulators halted sales of the device in the U.S.West Virginia on Wednesday sued Johnson & Johnson over its marketing of a surgical mesh used to treat pelvic conditions in women after regulators halted sales of the device in the U.S. The state's attorney general, Patrick Morrisey, filed a consumer protection case against the company in Monongalia County, saying it misrepresented the risks and effectiveness of the medical implant. Washington, California, Kentucky and Mississippi have filed similar suits against Johnson & Johnson.

West Virginia Sues Johnson & Johnson Over Pelvic Mesh After Regulators Halt Sales | KTLA

News about Johnson & Johnson, including commentary and archival articles published in The New York Times.News about Johnson & Johnson, including commentary and archival articles published in The New York Times.

“Jury says Johnson & Johnson must pay US$8-billion in case over male breast growth linked to #Risperdal via ⁦@globebusiness⁩ https://t.co/EVIXgFzsYA”

André Picard on Twitter: "Jury says Johnson & Johnson must pay US$8-billion in case over male breast growth linked to #Risperdal via ⁦@globebusiness⁩ https://t.co/EVIXgFzsYA"

““jury on Tues­day or­dered John­son & John­son to pay $8 bil­lion in dam­ages to a Mary­land man who said his use of J&J’s an­tipsy­chotic Risperdal as a child caused en­larged breasts and the com­pany failed to prop­erly warn of this risk” https://t.co/S7Ew3yvQIN from @Loftus”

Arielle Duhaime-Ross (she/her) on Twitter: "“jury on Tues­day or­dered John­son & John­son to pay $8 bil­lion in dam­ages to a Mary­land man who said his use of J&J’s an­tipsy­chotic Risperdal as a child caused en­larged breasts and the com­pany failed to prop­erly warn of this risk” https://t.co/S7Ew3yvQIN from @Loftus… https://t.co/UsRujKYd1X"

“A Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a Maryland man who said his use of J&J’s antipsychotic Risperdal as a child caused enlarged breasts and the company failed to properly warn of this risk. https://t.co/IyvWwyONaV”

Paul Vieira on Twitter: "A Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a Maryland man who said his use of J&J’s antipsychotic Risperdal as a child caused enlarged breasts and the company failed to properly warn of this risk. https://t.co/IyvWwyONaV"

“Philly jury hands Johnson & Johnson $8 billion verdict in Risperdal case over male breast growth https://t.co/IEfD9pPmjI”

Herman Wong on Twitter: "Philly jury hands Johnson & Johnson $8 billion verdict in Risperdal case over male breast growth https://t.co/IEfD9pPmjI"

Critics say $8 billion award against the pharmaceuticals giant is a symbol of consumer anger.

Whopping jury award against Johnson & Johnson sends a signal to drug industry

Johnson & Johnson will have to pay $8 billion in punitive damages after a man claims the company didn't warn young men that the drug Risperdal could grow breasts, a jury said Tuesday, according to Reuters.Johnson & Johnson will have to pay $8 billion in punitive damages after a man claims the company didn't warn young men that the drug Risperdal could grow breasts, a jury said Tuesday, according to Reuters. Nicholas Murray, 26, previously won $680,000 in the case over the antipsychotic drug Risperdal in the Philadelphia Court of Common Pleas.

Johnson & Johnson has to pay $8 billion after male breast growth linked to antipsychotic drug, jury says | FOX59

Johnson & Johnson has been ordered to pay $US8 billion (nearly $12 billion) in punitive damages in a case involving the way that the anti-psychotic drug Risperdal was marketed. Some male patients have argued that the drug caused them to grow large breasts and that the company downplayed this side effect when marketing...Johnson & Johnson has been ordered to pay $US8 billion (nearly $12 billion) in punitive damages in a case involving the way that the anti-psychotic drug Risperdal was marketed. Some male patients have argued that the drug caused them to grow large breasts and that the company downplayed this side effect when marketing...

Johnson & Johnson Ordered To Pay $8 Billion In Risperdal Case Involving Male Breast Growth | Gizmodo Australia

Johnson & Johnson will have to pay $8 billion in punitive damages after a man claims the company didn't warn young men that the drug Risperdal could grow breasts, a jury said Tuesday, according to Reuters.Johnson & Johnson will have to pay $8 billion in punitive damages after a man claims the company didn't warn young men that the drug Risperdal could grow breasts, a jury said Tuesday, according to Reuters. Nicholas Murray, 26, previously won $680,000 in the case over the antipsychotic drug Risperdal in the Philadelphia Court of Common Pleas.

Johnson & Johnson to Pay $8 Billion in Damages After Man Says He Developed Breasts After Taking Antipsychotic Drug | KTLA

Johnson & Johnson, the pharmaceutical giant, has to pay $8 billion to a man who developed an unwanted ...Johnson & Johnson, the pharmaceutical giant, has to pay $8 billion to a man who developed an unwanted ...

Johnson & Johnson to Pay $8B to Man Claiming His Breast Tissue Became Enlarged After Taking Drug

World News - NEW YORK: Johnson & Johnson (J&J) must pay US$8 billion (S$11 billion) in punitive damages to a man who previously won US$680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a... Read more at www.tnp.sgNEW YORK: Johnson & Johnson (J&J) must pay US$8 billion (S$11 billion) in punitive damages to a man who...

Johnson & Johnson must pay $11b over male breast growth, Latest World News - The New Paper

The drug Risperdal is at the center of the lawsuit, the plaintiff's attorneys argue it's linked to abnormal growth of female breast tissue in boys.The drug Risperdal is at the center of the lawsuit, the plaintiff's attorneys argue it's linked to abnormal growth of female breast tissue in boys.

Johnson & Johnson hit with $8B verdict over Risperdal | 9news.com

Philadelphia jury orders J&J (JNJ) to pay punitive damages of $8 billion to a man who claims that the use of Risperdal caused him to develop breasts.Philadelphia jury orders J&J (JNJ) to pay punitive damages of $8 billion to a man who claims that the use of Risperdal caused him to develop breasts.

J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case

A jury has ordered Johnson & Johnson to pay $8 billion in damages in a case where a man claims the company didn’t warn men that a drug could cause breast growth.A jury has ordered Johnson & Johnson to pay $8 billion in damages in a case where a man claims the company didn’t warn men that a drug could cause breast growth.

Johnson & Johnson ordered to pay $8B after male breast growth linked to drug